These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26502639)
1. Bioreducible Micelles with Endosomal Buffering and Multidrug Resistance-Reversing Function Enhance Anti-Tumor Efficacy of Doxorubicin. Yin Q; Shen J; Yu H; Huang Y; Zhang Z; Li Y J Biomed Nanotechnol; 2015 Oct; 11(10):1764-75. PubMed ID: 26502639 [TBL] [Abstract][Full Text] [Related]
2. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer. Tang S; Yin Q; Zhang Z; Gu W; Chen L; Yu H; Huang Y; Chen X; Xu M; Li Y Biomaterials; 2014 Jul; 35(23):6047-59. PubMed ID: 24797883 [TBL] [Abstract][Full Text] [Related]
3. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated pH-Dependent Thermo-Sensitive Copolymer: In Vitro and In Vivo Evaluation. Zhao H; Tao L; Yu R; Yuan H; Lan M J Nanosci Nanotechnol; 2015 Aug; 15(8):5553-8. PubMed ID: 26369116 [TBL] [Abstract][Full Text] [Related]
5. Carbon Nanotube-Mediated Photothermal Disruption of Endosomes/Lysosomes Reverses Doxorubicin Resistance in MCF-7/ADR Cells. Pai CL; Chen YC; Hsu CY; Su HL; Lai PS J Biomed Nanotechnol; 2016 Apr; 12(4):619-29. PubMed ID: 27301189 [TBL] [Abstract][Full Text] [Related]
6. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634 [TBL] [Abstract][Full Text] [Related]
7. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis. Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312 [TBL] [Abstract][Full Text] [Related]
8. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552 [TBL] [Abstract][Full Text] [Related]
9. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [TBL] [Abstract][Full Text] [Related]
10. Effect of hydrophobicity of core on the anticancer efficiency of micelles as drug delivery carriers. Sun CY; Ma YC; Cao ZY; Li DD; Fan F; Wang JX; Tao W; Yang XZ ACS Appl Mater Interfaces; 2014 Dec; 6(24):22709-18. PubMed ID: 25426800 [TBL] [Abstract][Full Text] [Related]
11. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein. Jin Y; Zhang Z; Zhao T; Liu X; Jian L J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136 [TBL] [Abstract][Full Text] [Related]
12. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery. Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122 [TBL] [Abstract][Full Text] [Related]
13. Reduction-responsive polypeptide nanogel delivers antitumor drug for improved efficacy and safety. Huang K; Shi B; Xu W; Ding J; Yang Y; Liu H; Zhuang X; Chen X Acta Biomater; 2015 Nov; 27():179-193. PubMed ID: 26320542 [TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance. Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991 [TBL] [Abstract][Full Text] [Related]
15. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
16. Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance. Yin Q; Shen J; Zhang Z; Yu H; Chen L; Gu W; Li Y Biomacromolecules; 2013 Jul; 14(7):2242-52. PubMed ID: 23682680 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers. Raja MA; Arif M; Feng C; Zeenat S; Liu CG J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. Lee ES; Na K; Bae YH J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623 [TBL] [Abstract][Full Text] [Related]
19. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer. Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of galactosylated glycol chitosan micelles and its potential use for hepatoma-targeting delivery of doxorubicin. Yu JM; Li WD; Lu L; Zhou XY; Wang DY; Li HM; Xu XY; Chen J J Mater Sci Mater Med; 2014 Mar; 25(3):691-701. PubMed ID: 24338380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]